Economic Analysis in Genomic Medicine
CDC paper: Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.
Scott D. Grosse. Genetics in Medicine (2014)
Scott D. Grosse. Genetics in Medicine (2014)
The economic value of personalized medicine tests: what we know and what we need to know.
Kathryn A Phillips et al. Genetics in Medicine (2013)
Kathryn A Phillips et al. Genetics in Medicine (2013)
Selected Recent Economic Analyses:
Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer
Bentley TG, et al. J Med Econ 2014 Apr
Bentley TG, et al. J Med Econ 2014 Apr
Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer
Roth JA, et al. Oncologist 2014 Apr
Roth JA, et al. Oncologist 2014 Apr
Cost-effectiveness of pharmacogenetics-guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation
Pink J, et al. Clin Pharmacol Ther 2014 Feb;95(2):199-207
Pink J, et al. Clin Pharmacol Ther 2014 Feb;95(2):199-207
Cost-effectiveness analysis of Mammostrat(R) compared with Oncotype DX(R) to inform the treatment of breast cancer
Mislick K, et al. Clinicoecon Outcomes Res 2014;6:37-47
Mislick K, et al. Clinicoecon Outcomes Res 2014;6:37-47
Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population
Saokaew S, et al. PLoS One 2014;9(4):e94294
Saokaew S, et al. PLoS One 2014;9(4):e94294
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome
Kazi DS, et al. Ann Intern Med 2014 Feb;160(4)
Kazi DS, et al. Ann Intern Med 2014 Feb;160(4)
No hay comentarios:
Publicar un comentario